The U.S. Department of Justice announced that a Massachusetts-based laboratory has agreed to pay nearly $27 million to settle claims that they improperly billed federal healthcare programs for lab tests.
The settlement resolves allegations that the company, Laboratory Boston Heart Diagnostics Corporation (Boston Heart), of Framingham, Mass., considered with other entities to pay kickbacks to doctors disguised as “investment returns.”
From 2015-2017, the company allegedly agreed to provide lab-testing services to small hospitals in Texas in exchange for per-test payments.
Boston Heart allegedly helped the MSOs find physicians, referred interested physicians to the MSOs and worked with the MSOs in “selling” the money-for-referrals scheme to physicians.
